[Brugada syndrome : Risk stratification and prevention of sudden cardiac death]

Area of Science:

• Cardiology
• Genetics
• Electrophysiology

Background:

• Brugada syndrome is an inherited cardiac condition characterized by specific ECG abnormalities.
• It predisposes individuals to life-threatening ventricular arrhythmias, syncope, and sudden cardiac death.
• Accurate diagnosis and risk stratification are crucial for effective management.

Purpose of the Study:

• To provide an updated overview of risk stratification strategies for Brugada syndrome.
• To discuss emerging therapeutic options beyond the standard implantable cardioverter-defibrillator (ICD).

Main Methods:

• Review of current literature on Brugada syndrome diagnosis and management.
• Analysis of recent advancements in risk stratification tools.
• Evaluation of novel therapeutic approaches.

Main Results:

• ECG diagnosis of Brugada syndrome remains complex.
• Individualized risk stratification is essential for primary prevention.
• Non-ICD therapeutic strategies are under investigation.

Conclusions:

• Current risk stratification methods for Brugada syndrome require refinement.
• Novel therapeutic avenues beyond ICD implantation hold promise for patient management.
• Further research is needed to establish efficacy and safety of new treatments.